FR2316933A1 - Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. - Google Patents
Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales.Info
- Publication number
- FR2316933A1 FR2316933A1 FR7620325A FR7620325A FR2316933A1 FR 2316933 A1 FR2316933 A1 FR 2316933A1 FR 7620325 A FR7620325 A FR 7620325A FR 7620325 A FR7620325 A FR 7620325A FR 2316933 A1 FR2316933 A1 FR 2316933A1
- Authority
- FR
- France
- Prior art keywords
- pts
- amino acid
- liver disorders
- mixts
- phenylalanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 title abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 210000003734 kidney Anatomy 0.000 title abstract 2
- 208000017169 kidney disease Diseases 0.000 title abstract 2
- 201000006370 kidney failure Diseases 0.000 title abstract 2
- 208000019423 liver disease Diseases 0.000 title abstract 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 title abstract 2
- 229930182817 methionine Natural products 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- AGPKZVBTJJNPAG-AKGZTFGVSA-N (2s)-2-amino-3-methylpentanoic acid Chemical compound CCC(C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-AKGZTFGVSA-N 0.000 abstract 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- 208000010444 Acidosis Diseases 0.000 abstract 1
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 230000007950 acidosis Effects 0.000 abstract 1
- 208000026545 acidosis disease Diseases 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 230000007882 cirrhosis Effects 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229960005190 phenylalanine Drugs 0.000 abstract 1
- 230000022558 protein metabolic process Effects 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752530246 DE2530246A1 (de) | 1975-07-07 | 1975-07-07 | L-aminosaeuregemische fuer parenterale oder orale anwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2316933A1 true FR2316933A1 (fr) | 1977-02-04 |
| FR2316933B1 FR2316933B1 (enExample) | 1979-06-29 |
Family
ID=5950870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7620325A Granted FR2316933A1 (fr) | 1975-07-07 | 1976-07-02 | Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2530246A1 (enExample) |
| FR (1) | FR2316933A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2434622A1 (fr) * | 1978-09-04 | 1980-03-28 | Otsuka Pharma Co Ltd | Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer |
| FR2435247A1 (fr) * | 1978-09-08 | 1980-04-04 | Ajinomoto Kk | Solution d'amino-acides pour la nutrition par voie intraveineuse |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2531204C2 (de) * | 1975-07-12 | 1987-01-22 | Fresenius AG, 6380 Bad Homburg | L-Aminosäuregemische für die parenterale oder orale Ernährung |
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| US5646187A (en) * | 1992-05-20 | 1997-07-08 | Ab Erik Vinnars | Use of alpha-ketoglutarate |
| IT1289754B1 (it) * | 1996-12-16 | 1998-10-16 | Professional Dietetics Srl | Composizioni a base di aminoacidi |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260189A1 (de) * | 1971-12-09 | 1973-06-20 | Hossein Ghadimi | Injizierbare aminosaeurepraeparate |
| FR2215212A1 (enExample) * | 1973-01-18 | 1974-08-23 | Seperic |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1667887C2 (de) * | 1968-02-09 | 1978-09-28 | Knauff, Hans Georg, Prof. Dr., 3551 Dagobertshausen | Aminosäurelösung zur parenteralen Infusion |
| AT297935B (de) * | 1968-05-09 | 1972-04-10 | Astra Ab | Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen |
| GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
| DE2335215B2 (de) * | 1972-07-13 | 1979-04-05 | The Johns Hopkins University, Baltimore, Md. (V.St.A.) | Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen |
| GB1442154A (en) * | 1973-04-30 | 1976-07-07 | Walser M | Composition for promotion of protein synthesis and suppression of urea formation in the body |
-
1975
- 1975-07-07 DE DE19752530246 patent/DE2530246A1/de active Granted
-
1976
- 1976-07-02 FR FR7620325A patent/FR2316933A1/fr active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260189A1 (de) * | 1971-12-09 | 1973-06-20 | Hossein Ghadimi | Injizierbare aminosaeurepraeparate |
| FR2215212A1 (enExample) * | 1973-01-18 | 1974-08-23 | Seperic |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2434622A1 (fr) * | 1978-09-04 | 1980-03-28 | Otsuka Pharma Co Ltd | Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer |
| FR2435247A1 (fr) * | 1978-09-08 | 1980-04-04 | Ajinomoto Kk | Solution d'amino-acides pour la nutrition par voie intraveineuse |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2530246A1 (de) | 1977-01-13 |
| DE2530246C2 (enExample) | 1989-08-03 |
| FR2316933B1 (enExample) | 1979-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7907393L (sv) | Aminosyralosning for intravenos neringstillforsel | |
| CA2177195A1 (en) | Method and composition for treating renal failure | |
| FR2316933A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. | |
| Miller et al. | Purification, properties, and identity of liver mitochondrial tyrosine aminotransferase | |
| DE3481157D1 (de) | Diaetetischer zusatz zur beeinflussung des schlafes. | |
| DE69921435D1 (de) | Verfahren zur Inaktivierung vom umhüllten Viren in einem Viruspräparat mit Adenoviren | |
| GB1489447A (en) | Amino acid supplements | |
| Sarkar et al. | Separation of cu (ii)–amino acid complexes and evidence for the existence of histidine–cu (ii)–glutamine and histidine–cu (ii)–serine complexes at physiological pH | |
| NO865217L (no) | Fremgangsmaate for fremstilling av anti-uremiapreparater. | |
| IE39051B1 (en) | New peptides and processes for their manufacture | |
| FR2317919A1 (fr) | Melanges contenant des l-aminoacides et des hydroxy- et/ou ceto-acides, et leur utilisation therapeutique | |
| DK0399341T3 (da) | Vandigt præparat til parenteral ernæring | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| WO1986002555A3 (en) | Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof | |
| Mun et al. | Protein and Amino Acid Composition of VVater Cress, Oenanthe stolonifera DC | |
| GB1442154A (en) | Composition for promotion of protein synthesis and suppression of urea formation in the body | |
| FR2365552A1 (fr) | Melange contenant des l-aminoacides essentiels et non essentiels, pour le traitement des insuffisances hepatiques | |
| MA20303A1 (fr) | Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels. | |
| GB1131937A (en) | A process for improving and enhancing the palatability of foods, seasonings or beverages | |
| FR2070149A1 (en) | Hypocalcemiant calcitonin m derivatives | |
| FR2317918A1 (fr) | Solutions d'aminoacides pour perfusion, pour prematures et enfants en bas age | |
| Dollar et al. | Sulfhydryl content of tuna myoglobin | |
| Figenschou et al. | Studies on the biosynthesis of gramicidin S in a cell-free system from Bacillus brevis. Further attempts to elucidate its mechanism of synthesis | |
| ES2132021A1 (es) | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. | |
| Yoshida et al. | Purification, crystallization and properties of tryptophanase from Proteus rettgeri |